Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03657069 · ClinicalTrials.gov registry record · NA
Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT03657069: Completed NA study, sponsored by Stanford University.
NCT03657069 is a NA study that has completed, run by Stanford University. The registered enrollment target is 11 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03657069, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This phase 1 trial studies how well Blossom Smart Expander Technology works in breast reconstruction in participants with breast cancer undergoing mastectomy. Blossom Smart Expander Technology allows for slow and continuous injection of small amounts of saline, from an external pouch and based on precise pressure and volume measurements, into breast expander implants. It may help in achieving the same reconstructive goals as conventional tissue expansion in a shorter period of time and while avoiding frequent injections through the skin, which cause patient discomfort and require many clinic visits.
Interventions
- DEVICE Blossom
- OTHER Breast-Q -Reconstruction module (preoperative) version 2.0 satisfaction with breasts questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-08-19 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03657069
The ClinicalTrials.gov registry entry for NCT03657069 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blossom is the first listed.
NCT03657069 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03657069 about?
NCT03657069 is a clinical study titled "Blossom Smart Expander Technology in Breast Reconstruction in Participants With Breast Cancer Undergoing Mastectomy". This phase 1 trial studies how well Blossom Smart Expander Technology works in breast reconstruction in participants with breast cancer undergoing mastectomy. Blossom Smart Expander Technology allows for slow and continuous injection of small amounts of saline, from an external pouch and based on pr...
What is the current status of trial NCT03657069?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-08-01. Estimated completion is 2020-08-19.
What interventions are being tested in trial NCT03657069?
The interventions under investigation include: Blossom (DEVICE), Breast-Q -Reconstruction module (preoperative) version 2.0 satisfaction with breasts questionnaire (OTHER).
Who is sponsoring clinical trial NCT03657069?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.